4.1 Article

A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany

Carlo Lazzaro et al.

Summary: This study aimed to estimate the cost-utility and economic value of STN1013001, a latanoprost cationic emulsion, compared to other latanoprost formulations in patients with open-angle glaucoma or ocular hypertension and concomitant ocular surface disease in Germany. The results showed that STN1013001 was more cost-effective and produced more quality-adjusted life years (QALYs) compared to latanoprost.

CLINICAL OPHTHALMOLOGY (2022)

Article Ophthalmology

Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France

Carlo Lazzaro et al.

Summary: This study investigated the cost utility of STN1013001 compared to Latanoprost in patients with OAG/OHT and concomitant OSD in France. The results showed that over a 5-year period, STN1013001 resulted in an incremental 0.35 QALYs gained at an incremental cost of euro7.39 compared to Latanoprost, resulting in an ICUR of euro21.26. Sensitivity analyses confirmed the robustness of the baseline results.

JOURNAL OF OPHTHALMOLOGY (2022)

Article Health Care Sciences & Services

Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy

Antonio Maria Fea et al.

Summary: The study evaluated the cost-effectiveness of iStent inject (R) device with concurrent cataract surgery versus cataract surgery alone in patients with mild-to-moderate POAG. Results indicated that iStent inject (R) + cataract surgery is a cost-effective option from the Italian NHS perspective for treating patients with mild-to-moderate POAG.

BMC HEALTH SERVICES RESEARCH (2021)

Article Ophthalmology

Impact of Ocular Surface Disease Treatment in Patients with Glaucoma

Ana Luiza Mylla Boso et al.

CLINICAL OPHTHALMOLOGY (2020)

Article Health Care Sciences & Services

Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling

Janneke P. C. Grutters et al.

INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2019)

Article Cell & Tissue Engineering

Early health economic modelling of single-stage cartilage repair. Guiding implementation of technologies in regenerative medicine

Tommy S. de Windt et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)

Article Ophthalmology

Treatment patterns and medication adherence of patients with glaucoma in South Korea

Chan Yun Kim et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2017)

Review Medicine, Research & Experimental

Quality of Life in Glaucoma: A Review of the Literature

Luciano Quaranta et al.

ADVANCES IN THERAPY (2016)

Article Health Care Sciences & Services

Early decision-analytic modeling - a case study on vascular closure devices

Alina Brandes et al.

BMC HEALTH SERVICES RESEARCH (2015)

Review Pharmacology & Pharmacy

Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

Frederic Lallemand et al.

JOURNAL OF DRUG DELIVERY (2012)

Article Economics

Exploring uncertainty in cost-effectiveness analysis

Karl Claxton

PHARMACOECONOMICS (2008)

Article Economics

German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus

J. -Matthias Graf von der Schulenburg et al.

VALUE IN HEALTH (2008)

Article Cell & Tissue Engineering

Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra

Helen McAteer et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2007)

Article Economics

Expected value of information and decision making in HTA

Simon Eckermann et al.

HEALTH ECONOMICS (2007)

Article Medicine, General & Internal

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

Stefan Holmstrom et al.

CURRENT MEDICAL RESEARCH AND OPINION (2006)

Article Ophthalmology

Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease

RP Mills et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)

Article Ophthalmology

Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication

PJ Pisella et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2002)